Atıf İçin Kopyala
Ozturk C., DUMAN ÖZTÜRK S., OKCU O., Sen B., YASİN A. İ., BEDİR R.
ISTANBUL MEDICAL JOURNAL, cilt.23, sa.4, ss.241-246, 2022 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
23
Sayı:
4
-
Basım Tarihi:
2022
-
Doi Numarası:
10.4274/imj.galenos.2022.69741
-
Dergi Adı:
ISTANBUL MEDICAL JOURNAL
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.241-246
-
Anahtar Kelimeler:
Intratumoral budding, neoadjuvant chemotherapy, treatment response, breast cancer, core biopsy, CHEMOTHERAPY, KI-67, PROGNOSIS, SURVIVAL
-
Kocaeli Üniversitesi Adresli:
Evet
Özet
Introduction: Neoadjuvant chemotherapy (NAC) is used with increasing frequency in breast cancers. Various clinicopathological parameters predict treatment response (TR). Tumor budding (TB), which is a prognostic parameter in many cancers, can be considered the first stage of the metastatic process. In our study, the relationship between TR and clinicopathological parameters and TB in core biopsy samples of patients before NAC was investigated.